Cooper Price to Free Cash Flow Ratio 2010-2024 | COO

Historical price to free cash flow ratio values for Cooper (COO) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Cooper Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-04-23 91.68 134.51
2024-01-31 23.31 $0.68 34.21
2023-10-31 19.48 $1.08 18.05
2023-07-31 24.45 $1.11 22.09
2023-04-30 23.84 $1.95 12.25
2023-01-31 21.81 $2.14 10.19
2022-10-31 17.08 $2.27 7.54
2022-07-31 20.43 $2.64 7.74
2022-04-30 22.56 $2.44 9.23
2022-01-31 24.89 $2.72 9.17
2021-10-31 26.05 $2.63 9.90
2021-07-31 26.35 $2.64 9.97
2021-04-30 25.67 $2.08 12.33
2021-01-31 22.74 $1.04 21.77
2020-10-31 19.93 $0.89 22.44
2020-07-31 17.67 $0.91 19.50
2020-04-30 17.91 $1.17 15.33
2020-01-31 21.67 $2.30 9.43
2019-10-31 18.18 $2.11 8.63
2019-07-31 21.07 $2.50 8.43
2019-04-30 18.11 $2.81 6.43
2019-01-31 17.41 $2.63 6.61
2018-10-31 16.13 $2.39 6.75
2018-07-31 16.27 $2.26 7.19
2018-04-30 14.28 $1.93 7.41
2018-01-31 15.28 $1.82 8.40
2017-10-31 15.00 $2.35 6.38
2017-07-31 15.22 $2.31 6.58
2017-04-30 12.51 $2.23 5.61
2017-01-31 11.52 $2.00 5.77
2016-10-31 10.99 $1.82 6.03
2016-07-31 11.39 $1.25 9.11
2016-04-30 9.55 $0.90 10.59
2016-01-31 8.18 $0.90 9.06
2015-10-31 9.51 $0.75 12.65
2015-07-31 11.04 $0.99 11.21
2015-04-30 11.11 $1.10 10.09
2015-01-31 9.83 $1.14 8.60
2014-10-31 10.22 $1.11 9.24
2014-07-31 10.03 $1.03 9.71
2014-04-30 8.22 $1.09 7.55
2014-01-31 7.75 $1.14 6.78
2013-10-31 8.05 $1.20 6.73
2013-07-31 7.94 $1.22 6.50
2013-04-30 6.88 $1.17 5.87
2013-01-31 6.32 $1.08 5.87
2012-10-31 5.98 $1.10 5.46
2012-07-31 4.69 $1.09 4.29
2012-04-30 5.49 $1.16 4.72
2012-01-31 4.49 $1.08 4.15
2011-10-31 4.31 $1.20 3.58
2011-07-31 4.76 $0.96 4.98
2011-04-30 4.66 $0.93 5.02
2011-01-31 3.57 $1.04 3.43
2010-10-31 3.07 $1.04 2.94
2010-07-31 2.42 $1.20 2.02
2010-04-30 2.42 $1.19 2.03
2010-01-31 2.20 $1.00 2.20
2009-10-31 1.74 $0.71 2.45
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.222B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.909B 18.71
Becton Dickinson (BDX) United States $67.707B 19.66
West Pharmaceutical Services (WST) United States $28.565B 48.29
Cardinal Health (CAH) United States $25.143B 15.11
Align Technology (ALGN) United States $23.470B 47.33
Labcorp (LH) United States $17.496B 14.94
Henry Schein (HSIC) United States $9.348B 16.17
DENTSPLY SIRONA (XRAY) United States $6.399B 16.86
Merit Medical Systems (MMSI) United States $4.307B 24.65
STAAR Surgical (STAA) United States $2.355B 74.14
Patterson (PDCO) United States $2.327B 11.15
CONMED (CNMD) United States $2.196B 20.67
Atrion (ATRI) United States $0.713B 36.74
Lifevantage (LFVN) United States $0.082B 13.34
Pro-Dex (PDEX) United States $0.066B 25.00
Biolase (BIOL) United States $0.005B 0.00